Search Results 921-930 of 15050 for ✔

  1. A Study to Predict Response to Virotherapy and Immunotherapy by Using an Ex-Vivo Three-Dimensional Patient-Derived Organoid Model of Pediatric Urological Cancers - Mayo Clinic

    The purpose of this study is threefold: the first aim is to use patient-derived fresh tumor tissue to create cell lines and 3D tumor models (i.e. organoids) ...

  2. Molecular Modulation of the Growth Plate - Clinical Trials

    About this study. The researchers are trying to identify molecular mechanisms that control growth plate mediated limb growth and identify agents that can be ...

  3. Kaiser G. Lim, M.D. - Doctors and Medical Staff - Mayo Clinic

    1997. Clinical Fellowship - Allergy and ImmunologyBoston University School of Medicine · 1995. Research Fellowship - Infectious DiseaseBeth Israel Hospital, ...

  4. Simultaneous liver transplantation with sleeve gastrectomy - Mayo Clinic

    Combined liver transplantation plus sleeve gastrectomy is an approach that cures liver disease and provides durable weight loss.

  5. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...

  6. Radiology - Doctors - Mayo Clinic

    Learn about the radiology expertise and services offered at Mayo Clinic to solve the most serious and complex medical questions for people who turn to the ...

  7. Health Topics - Mayo Clinic News Network

    DEAR MAYO CLINIC: I understand surgery is often included as part of the treatment plan for breast cancer. If I'm a candidate for lumpectomy but[...] ...

  8. A Study of Novel Biomarkers in Suspected Cardiogenic Shock - Mayo Clinic

    The purpose of this study is to assess biomarkers of Cardiogenic Shock (CS) which may be associated with the development of and outcomes after CS to provide ...

  9. Health Topics - Mayo Clinic News Network

    This week's episode of Tomorrow's Cure comes to you from the PlatforMed Conference, held in June 2025 in Minneapolis. The event brought together more than ...

  10. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab ( ...